Medtronic changes investor relations leadership ahead of diabetes spinout

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Medtronic has changed its investor relations leadership team in preparation for spinning off its diabetes division, the company said on Friday. Ryan Weispfenning, vice president and head of investor relations at Medtronic, is moving to the diabetes spinout MiniMed. Weispfenning will establish and lead the investor relations function at MiniMed. Medtro ...